Spasticity Treatment Beyond Botulinum Toxins - 19/03/24
Doi : 10.1016/j.pmr.2023.06.009
Sheng Li, MD, PhD a, b, ⁎ 
, Paul Winston, MD c, d, Manuel F. Mas, MD e
, Paul Winston, MD c, d, Manuel F. Mas, MD e a Department of Physical Medicine and Rehabilitation, McGovern Medical School, University of Texas Health Science Center – Houston, Houston, TX, USA
b TIRR Memorial Herman
c Division of Physical Medicine and Rehabilitation, University of British Columbia, Victoria, British Columbia, Canada
d Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Victoria, British Columbia, Canada
e Department of Physical Medicine and Rehabilitation, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico
∗Corresponding author.
Riassunto |
Botulinum toxin (BonT) is the mainstream treatment option for post-stroke spasticity. BoNT therapy may not be adequate in those with severe spasticity. There are a number of emerging treatment options for spasticity management. In this paper, we focus on innovative and revived treatment options that can be alternative or complementary to BoNT therapy, including phenol neurolysis, cryoneurolysis, and extracorporeal shock wave therapy.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Spasticity, Stroke, Phenol neurolysis, Cryoneurolysis, Extracorporeal shock wave therapy (ESWT)
Mappa
© 2023
Elsevier Inc. Tutti i diritti riservati.
Vol 35 - N° 2
P. 399-418 - Maggio 2024 Ritorno al numero
Articolo precedente
- Technological Advances in Stroke Rehabilitation : Robotics and Virtual Reality
- Deepthi Rajashekar, Alexa Boyer, Kelly A. Larkin-Kaiser, Sean P. Dukelow
- A Review of Poststroke Aphasia Recovery and Treatment Options
- Victoria E. Tilton-Bolowsky, Argye E. Hillis
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?